Performance Evaluation of the Automated Coagulation Analyzer Coapresta 2000.
- Author:
Yeong Chun PARK
1
;
Jinsook LIM
;
Yong Hyun KO
;
Ji Myung KIM
;
Sun Hoe KOO
;
Kye Chul KWON
Author Information
1. Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Korea. kwon8004@gmail.com
- Publication Type:Original Article
- Keywords:
Coapresta 2000;
Coagulation;
Analyzer;
Prothrombin time;
Partial thromboplastin time
- MeSH:
Citrates;
Citric Acid;
Latex;
Partial Thromboplastin Time;
Plasma;
Prothrombin Time;
Sodium
- From:Journal of Laboratory Medicine and Quality Assurance
2013;35(1):8-12
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The Coapresta 2000 (Sekisui Medical Co., Japan) is a newly developed, fully automated coagulation analyzer that can perform clotting time assays using the synthetic substrate method and the latex turbidimetric method. In this study, we evaluated the analytical performance of the Coapresta 2000 for measuring prothrombin time (PT) and activated partial thromboplastin time (aPTT), and compared the results to those of the CA-7000 (Sysmex Co., Japan) and ACL-9000 (Instrumentation Laboratory, USA) analyzers. METHODS: The Coapresta 2000 was evaluated for its precision at measuring PT and aPTT in fresh normal plasma and fresh abnormal plasma. Three hundred venous blood specimens were collected in 3.2% sodium citrate tubes, and PT and aPTT results were compared among the Coapresta 2000, ACL-9000, and CA-7000 analyzers. RESULTS: The coefficients of variation of both intra- and inter-assays for the Coapresta 2000 were <5% for PT and aPTT in the normal and pathological ranges. The results obtained using the Coapresta 2000 analyzer correlated well with those obtained using the ACL-9000 analyzer (r in the range of 0.9799-0.9886) except for aPTT (r=0.7626) and with those obtained using the CA-7000 analyzer (r in the range of 0.8258 - 0.9735). CONCLUSIONS: The Coapresta 2000 provided satisfactory precision, and the results obtained correlated well with those obtained using the existing CA-7000 and ACL-9000 coagulation analyzers. We conclude that the Coapresta 2000 would be a useful analyzer for routine coagulation tests.
